Find link

language:

Find link is a tool written by Edward Betts.

searching for Rofecoxib 13 found (470 total)

alternate case: rofecoxib

Drug Industry Documents Archive (543 words) [view diff] exact match in snippet view article find links to article

and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation". JAMA: The Journal of the American

UGT2B15 (845 words) [view diff] exact match in snippet view article find links to article

Zhan J, Cook CS, et al. (2003). "Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism". Drug Metab. Dispos. 31 (5): 652–8. doi:10.1124/dmd.31.5.652

UGT1A3 (905 words) [view diff] exact match in snippet view article find links to article

Ings RM, Breau AP (May 2003). "Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism". Drug Metabolism and Disposition. 31 (5): 652–8. doi:10.1124/dmd

Criticism of the Food and Drug Administration (5,595 words) [view diff] exact match in snippet view article find links to article

once evidence shows them to be unsafe. Rezulin (troglitazone) and Vioxx (rofecoxib) are high-profile examples of drugs approved by the FDA which were later

Rheumatoid arthritis (17,107 words) [view diff] exact match in snippet view article find links to article

caution in those with gastrointestinal, cardiovascular, or kidney problems. Rofecoxib was withdrawn from the global market as its long-term use was associated

Eric Feigl-Ding (2,174 words) [view diff] exact match in snippet view article find links to article

Commission - European Commission. "New, Comprehensive Analysis Shows Rofecoxib (VIOXX), But Not Other COX-2 Inhibitor Drugs, Increases Risks of Adverse

Reporting bias (2,765 words) [view diff] exact match in snippet view article find links to article

for drugs (e.g., selective serotonin uptake inhibitors, rosiglitazone, rofecoxib) has resulted in additional publications, too numerous to review, indicating

Seeding trial (2,590 words) [view diff] exact match in snippet view article find links to article

(October 2003). "Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled

Garret A. FitzGerald (936 words) [view diff] exact match in snippet view article find links to article

increasing cardiovascular risk, was instrumental in the withdrawal of Vioxx (rofecoxib) from the U.S. market in 2004. FitzGerald is a member of the National

UCD School of Medicine (1,578 words) [view diff] exact match in snippet view article find links to article

increasing cardiovascular risk, was instrumental in the withdrawal of Vioxx (rofecoxib) from the U.S. market in 2004 Michael Fitzsimons – 8-time All-Ireland

Food and Drug Administration (11,643 words) [view diff] exact match in snippet view article find links to article

2017. Bresalier, RS (March 2005). "Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial". N. Engl. J. Med. 352 (11):

Harlan Krumholz (4,113 words) [view diff] exact match in snippet view article find links to article

and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation". JAMA. 299 (15): 1800–1812. doi:10

Alex Bekker (1,750 words) [view diff] exact match in snippet view article find links to article

Evaluation of Preoperative Administration of the Cyclooxygenase-2 Inhibitor Rofecoxib for the Treatment of Postoperative Pain after Lumbar Disc Surgery. Neurosurgery